Current Issues Anti-anginal Drug Therapy for the stable coronary Heart Disease (CHD)

被引：0
|
作者：
Gottsauner-Wolf, M. [1 ]
机构：
[1] Med Univ Wien, Univ Klin Innere Med 2, Abt Kardiol, Wahringer Gurtel 18-20, A-1090 Vienna, Austria
来源：
JOURNAL FUR KARDIOLOGIE | 2019年 / 26卷 / 3-4期
关键词：
ARTERY-DISEASE; ANGINA; TRIAL; RANOLAZINE; NIFEDIPINE; EXERCISE; ATENOLOL; TRIMETAZIDINE; COMBINATION; DYSFUNCTION;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：83 / 86
页数：4
相关论文
共 50 条
  • [11] PERHEXILINE-MALEATE, A NEW ANTI-ANGINAL DRUG
    MASHFORD, ML
    HOROWITZ, JD
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1977, 4 (02) : 206 - 206
  • [12] ASSOCIATION BETWEEN USE OF ANTI-ANGINAL MEDICATIONS FOR STABLE CORONARY DISEASE AND RATES OF PERCUTANEOUS CORONARY INTERVENTION: A REPORT FROM THE NCDR®
    Borden, William
    Spertus, John
    Mushlin, Alvin I.
    Roe, Matthew
    Kaltenbach, Lisa
    Redberg, Rita
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 59 (13) : E1812 - E1812
  • [13] Ranolazine: an anti-anginal drug with further therapeutic potential
    Reffelmann, Thorsten
    Kloner, Robert A.
    EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2010, 8 (03) : 319 - 329
  • [14] Anti-anginal and anti-ischemic effects of the if current inhibitor ivabradine versus atenolol in stable angina
    Tardif, JC
    Ford, I
    Tendera, M
    Fox, K
    Bourassa, MG
    CIRCULATION, 2003, 108 (17) : 590 - 590
  • [15] Therapeutic potential of nicorandil beyond anti-anginal drug: A review on current and future perspectives
    Singh, Dhirendra
    Singh, Randhir
    Akindele, Abidemi James
    HELIYON, 2024, 10 (07)
  • [16] Non-haemodynamic anti-anginal agents in the management of patients with stable coronary artery disease and diabetes: A review of the evidence
    Ambrosio, Giuseppe
    Tamargo, Juan
    Grant, Peter J.
    DIABETES & VASCULAR DISEASE RESEARCH, 2016, 13 (02): : 98 - 112
  • [17] DILTIAZEM IN PATIENTS UNRESPONSIVE TO CONVENTIONAL ANTI-ANGINAL THERAPY
    ALLEN, JW
    SHAH, AA
    TANABE, J
    HEMBERGER, J
    WALKER, SD
    CIRCULATION, 1980, 62 (04) : 28 - 28
  • [18] Does the exercise protocol matter when assessing the anti-anginal effects of drug therapy?
    Patel, DJ
    Mulcahy, D
    Norrie, J
    Sparrow, J
    Wright, C
    Ford, I
    Fox, KM
    EUROPEAN HEART JOURNAL, 1995, 16 (12) : 1773 - 1779
  • [19] EFFECT OF AMIODARONE, A NEW ANTI-ANGINAL DRUG, ON CARDIAC MUSCLE
    SINGH, BN
    VAUGHANW.EM
    BRITISH JOURNAL OF PHARMACOLOGY, 1970, 39 (04) : 657 - &
  • [20] MOLSIDOMINE, AN EFFECTIVE LONG-ACTING ANTI-ANGINAL DRUG
    BALAKUMARAN, K
    HUGENHOLTZ, PG
    TIJSSEN, JGP
    CHADHA, DR
    EUROPEAN HEART JOURNAL, 1983, 4 (09) : 655 - 661
12345